Skip to main content
. 2018 Aug 1;6(8):E907–E913. doi: 10.1055/a-0624-2266

Table 4. Mucosa visibility.

Optimal visibility
Split dose regimen (%) Full dose regimen (%) P value
ITT population
  • PMF 104 n = 191

60 50.8 0.07
  • PEG-ASC n = 192

65.6 43.5 0.01

ITT, intention-to-treat.